Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,116 public trials 1,860 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, not recruiting

MYLUNG Consortium Study Protocol 2

NCT05644808

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Southern Cancer Center, PC Daphne, Alabama, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Woodlands Medical Specialists, PA Pensacola, Florida, United States
  • Illinois Cancer Specialists Niles, Illinois, United States
View all 18 locations
View Trial Details
Active, not recruiting

Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

NCT05096663

Conditions
Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +16 more
Locations
  • Veterans Administration Medical Center - Birmingham Birmingham, Alabama, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 350 locations
View Trial Details
Active, not recruiting

A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer

NCT05653752

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • BRCR Global Plantation, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Next Oncology-Dallas Irving, Texas, United States
View all 13 locations
View Trial Details
Active, not recruiting

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

NCT04380636

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of South Alabama, Mitchell Cancer Institute ( Site 0003) Mobile, Alabama, United States
  • St. Bernards Medical Center ( Site 0089) Jonesboro, Arkansas, United States
  • St Joseph Heritage Healthcare-Oncology ( Site 0088) Fullerton, California, United States
  • Long Beach Memorial Medical Center ( Site 0006) Long Beach, California, United States
View all 205 locations
View Trial Details
Active, not recruiting

Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)

NCT04526691

Conditions
Advanced or Metastatic NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • Johns Hopkins Kimmel Cancer Center Washington D.C., District of Columbia, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 24 locations
View Trial Details
Active, not recruiting

A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer

NCT03807778

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Fujita Health University Hospital Toyoake, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • Kurume University Hospital Kurume, Fukuoka, Japan
View all 25 locations
View Trial Details

Related conditions